Organic Active Ingredients TRIZ Cases

Glycosylated cucurbitane tetracyclic triterpenoid compounds inhibit inflammation and reduce collagen deposition in lung tissue.

Replacing expensive enol triflate intermediates with stable vinyl iodide eliminates costly reagents and chromatographic purification steps.

Engineered immune cells secrete MDA-7/IL-24 fusion proteins to kill cancer cells while sparing normal tissue.

Trehalose treats pre-eclampsia by restoring autophagy to degrade cis-p-tau aggregates, addressing inadequate existing management approaches.

Specific amino acid ratios enable on-demand nitric oxide production, resolving the trade-off between efficacy and daily dosing frequency.

Segmented and mutated circumsporozoite proteins resolve low yield bottlenecks by eliminating destabilizing regions, enabling 300-fold higher antigen production.

Segmented ethanol fractionation removes oversulfated chondroitin sulfate impurities, ensuring high-purity heparin free from side-effect-causing contaminants.

Ergothioneine topical composition reduces UV-induced mtDNA deletion while preventing skin irritation from oxidative stress.

Spore-forming Bacillus coagulans bacteria in gummi candies survive harsh processing and gastrointestinal conditions to deliver sustained health benefits.

Converting glucose hydroxyl groups to acetal groups in compound K derivatives enhances binding to PRELID3b, resolving low bioavailability limits.

Small molecule inhibitors block tryptophan catabolism to restore immune function against tumor growth.

Activated carbon catalyzes carbohydrate dehydration to produce 5-hydroxymethyl-2-furfural, resolving device corrosion and catalyst removal issues.

Hot-melt extrusion disperses low-solubility carotenoids in a polymer matrix to improve bioavailability while eliminating solvent use.

Terminal alkyne bisbenzimidazoles inhibit E. coli topoisomerase I while sparing human enzymes.

Oxazolidinone hydroxamic acid derivatives act as dual inhibitors of 5-lipoxygenase and mast cell degranulation.

Methylphosphinic acid compositions protect mammalian mitochondria from oxidative stress damage, addressing the lack of effective aging reduction methods.

BioID2 biotin ligase mapping identifies alphavirus capsid interactions with host factors like IRAK1 to modulate immune signaling pathways.

A solid oral pharmaceutical composition uses microtablets with Krebs cycle precursor salts and mini-tablets with bicarbonate salts.

Para-aminohippuric acid reduces nephrotoxicity by competing with radiolabeled agents for renal transporter binding.

Hoga1 inhibitors reduce body weight and adipose tissue size while maintaining safety by avoiding broad-spectrum effects on other biological systems.

Aryl hydrocarbon receptor ligands induce regulatory T cells to suppress autoimmune destruction without global immune suppression.

Oral procaine concentrates in dorsal root ganglia via ion trapping to block voltage-gated sodium channels.

Macrocyclic pyrazolopyrimidines target the RIP2 kinase active site to block pro-inflammatory signaling pathways.

Replacing invasive injections, inhaled testosterone triggers brain signals to boost insulin and lower blood sugar.

Dual inhibition overcomes c-Met resistance by blocking alternative IGF-1R pathways while reducing toxicity.

Combining atosiban with a PGF2α receptor antagonist delays delivery onset in preterm labor cases.

SMER28 compounds treat ribosomal disorders by enhancing erythroid differentiation and reducing apoptosis, addressing inadequate therapeutic outcomes.

Adjusting the buffer pH to 4.6–7.0 prevents decomposition of single-stranded nucleic acids, maintaining over 80% content after four weeks at room conditions.

Modified siRNA reduces PD-L1 expression by binding CD274 mRNA, improving survival rates for hepatocellular carcinoma and hepatitis B.

Baseline protein measurements identify responsive subjects, resolving variability in GvHD therapeutic effectiveness.

Composite beads combine bleached plant material with fillers and binders to reduce tobacco content while maintaining structural integrity.

Polyol mediators protect calcium N5-methyl-tetrahydrofolate from oxidation, maintaining purity without expensive oxygen exclusion infrastructure.

Benzamide derivatives inhibit CETP to raise HDL and lower LDL cholesterol, addressing insufficient therapeutic efficacy in atherosclerosis treatment.

CRF1 receptor antagonists lower ACTH and androgen levels, reducing iatrogenic Cushing's syndrome risks from high-dose glucocorticoids.

Indole carboxamide compounds inhibit Bruton's tyrosine kinase to resolve stability and toxicity trade-offs in autoimmune disease treatment.

Combining atomoxetine and spironolactone enhances genioglossus muscle activity to reduce airway collapse during sleep.

Pidotimod treats psoriasis by modulating immune parameters, reducing PASI scores while avoiding the toxicity of traditional immunosuppressants.

Liposomal compositions encapsulate lipophilic bioactive agents to improve skin penetration while reducing formulation complexity through permeation enhancers.

Segmented block copolymers resolve burst release and low payload contradictions by localizing drug encapsulation in the hydrophobic core.

Halogen-substituted ERK inhibitors improve chemical stability and pharmacokinetics, overcoming resistance in cancer therapy.

Telomerase inhibitors treat myelofibrosis with spliceosome mutations by reversing bone marrow fibrosis while managing toxicity via dose adjustment.

Decaffeinated green coffee extract inhibits the glucose-6-phosphatase system to lower blood glucose levels while avoiding caffeine-induced insulin resistance.

SKI-606 inhibits tyrosine kinase activity to manage imatinib-resistant BcrAbl positive leukemia.

Combining ribavirin, GDC-0449, and cytarabine overcomes resistance by reducing eIF4E levels.

Amorphous spray-dried dispersion stabilizes the active ingredient to maintain consistent plasma concentrations despite poor solubility.